Research Roundup

The sudden loss of vision following dermal filler procedures is rare; however, it can happen and can have catastrophic results. The aim of this study was to provide an update on the published cases of blindness following dermal filler injection that have occurred following a review of 98 cases since 2015, and to discuss strategies for prevention and management of this outcome.

In order to conduct this study, a literature review was carried out to identify all cases of visual complications caused by dermal filler injections between January 2015 and September 2018.

The results showed that there were 48 new published cases of partial or complete vision loss following dermal filler injections since January 2015.

The areas of the face that were at highest risk for visual loss were the nasal region (56.3%), glabella (27.1%), forehead (18.8%), and nasolabial fold (14.6%). In 81.3% of these cases, Hyaluronic Acid dermal filler was used.

The most common symptoms experienced by patients included in this study were vision loss, pain, ophthalmoplegia and ptosis. In addition, skin changes were observed in 43.8% of cases and complications associated with the central nervous system were recorded in 18.8% of cases.